89 related articles for article (PubMed ID: 21570678)
1. The number of CD161 positive Th17 cells are decreased in head and neck cancer patients.
Kesselring R; Thiel A; Pries R; Wollenberg B
Cell Immunol; 2011; 269(2):74-7. PubMed ID: 21570678
[TBL] [Abstract][Full Text] [Related]
2. Immunological approach in the evaluation of regional lymph nodes of patients with squamous cell carcinoma of the head and neck.
Verastegui E; Morales R; Barrera JL; Müeller A; Guzman B; Meneses A; Alfaro G
Clin Immunol; 2002 Jan; 102(1):37-47. PubMed ID: 11781066
[TBL] [Abstract][Full Text] [Related]
3. The transient nature of the Th17 phenotype.
Annunziato F; Romagnani S
Eur J Immunol; 2010 Dec; 40(12):3312-6. PubMed ID: 21110314
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of prostaglandin E2 production by mononuclear cells and tumor cells in squamous cell carcinomas of the head and neck.
Milanovich MR; Snyderman CH; Wagner R; Johnson JT
Laryngoscope; 1995 Jan; 105(1):61-5. PubMed ID: 7837915
[TBL] [Abstract][Full Text] [Related]
5. Increased IL-17-producing CD4(+) T cells in patients with esophageal cancer.
Chen D; Hu Q; Mao C; Jiao Z; Wang S; Yu L; Xu Y; Dai D; Yin L; Xu H
Cell Immunol; 2012; 272(2):166-74. PubMed ID: 22082565
[TBL] [Abstract][Full Text] [Related]
6. Cytokines in head and neck cancer.
Pries R; Wollenberg B
Cytokine Growth Factor Rev; 2006 Jun; 17(3):141-6. PubMed ID: 16540364
[TBL] [Abstract][Full Text] [Related]
7. ESAT-6- and CFP-10-specific Th1, Th22 and Th17 cells in tuberculous pleurisy may contribute to the local immune response against Mycobacterium tuberculosis infection.
Qiao D; Yang BY; Li L; Ma JJ; Zhang XL; Lao SH; Wu CY
Scand J Immunol; 2011 Apr; 73(4):330-7. PubMed ID: 21223348
[TBL] [Abstract][Full Text] [Related]
8. Intratumoral recombinant human interleukin-12 administration in head and neck squamous cell carcinoma patients modifies locoregional lymph node architecture and induces natural killer cell infiltration in the primary tumor.
van Herpen CM; van der Laak JA; de Vries IJ; van Krieken JH; de Wilde PC; Balvers MG; Adema GJ; De Mulder PH
Clin Cancer Res; 2005 Mar; 11(5):1899-909. PubMed ID: 15756016
[TBL] [Abstract][Full Text] [Related]
9. Treatment to sustain a Th17-type phenotype to prevent skewing toward Treg and to limit premalignant lesion progression to cancer.
Young MR; Levingston CA; Johnson SD
Int J Cancer; 2016 May; 138(10):2487-98. PubMed ID: 26756968
[TBL] [Abstract][Full Text] [Related]
10. Enrichment in tumor-reactive CD8+ T-lymphocytes by positive selection from the blood and lymph nodes of patients with head and neck cancer.
Letessier EM; Heo DS; Okarma T; Johnson JT; Herberman RB; Whiteside TL
Cancer Res; 1991 Aug; 51(15):3891-9. PubMed ID: 1677310
[TBL] [Abstract][Full Text] [Related]
11. Lymphoid subpopulation changes in regional lymph nodes in squamous head and neck cancer.
Saxon A; Portis J
Cancer Res; 1977 Apr; 37(4):1154-8. PubMed ID: 300279
[TBL] [Abstract][Full Text] [Related]
12. Differentiation imbalance of Th1/Th17 in peripheral blood mononuclear cells might contribute to pathogenesis of Hashimoto's thyroiditis.
Shi Y; Wang H; Su Z; Chen J; Xue Y; Wang S; Xue Y; He Z; Yang H; Zhou C; Kong F; Liu Y; Yang P; Lu L; Shao Q; Huang X; Xu H
Scand J Immunol; 2010 Sep; 72(3):250-5. PubMed ID: 20696023
[TBL] [Abstract][Full Text] [Related]
13. Identification and functional analysis of tumor-infiltrating plasmacytoid dendritic cells in head and neck cancer.
Hartmann E; Wollenberg B; Rothenfusser S; Wagner M; Wellisch D; Mack B; Giese T; Gires O; Endres S; Hartmann G
Cancer Res; 2003 Oct; 63(19):6478-87. PubMed ID: 14559840
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of NK cell function against head and neck cancer in response to ss-isRNA requires TLR7.
Pries R; Wulff S; Kesselring R; Börngen K; Xie L; Wollenberg B
Int J Oncol; 2008 Nov; 33(5):993-1000. PubMed ID: 18949362
[TBL] [Abstract][Full Text] [Related]
15. The role of retinoic acid-related orphan receptor variant 2 and IL-17 in the development and function of human CD4+ T cells.
Crome SQ; Wang AY; Kang CY; Levings MK
Eur J Immunol; 2009 Jun; 39(6):1480-93. PubMed ID: 19449310
[TBL] [Abstract][Full Text] [Related]
16. Th17 cells in inflammation.
Kimura A; Kishimoto T
Int Immunopharmacol; 2011 Mar; 11(3):319-22. PubMed ID: 21035432
[TBL] [Abstract][Full Text] [Related]
17. Investigation of interleukin 10, 12 and 18 levels in patients with head and neck cancer.
Jebreel A; Mistry D; Loke D; Dunn G; Hough V; Oliver K; Stafford N; Greenman J
J Laryngol Otol; 2007 Mar; 121(3):246-52. PubMed ID: 17040593
[TBL] [Abstract][Full Text] [Related]
18. Increased prevalence of T(H)17 cells in the peripheral blood of patients with head and neck squamous cell carcinoma.
Li C; Zhao Y; Zhang W; Zhang W
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Jul; 112(1):81-9. PubMed ID: 21458322
[TBL] [Abstract][Full Text] [Related]
19. IL-9 promotes Th17 cell migration into the central nervous system via CC chemokine ligand-20 produced by astrocytes.
Zhou Y; Sonobe Y; Akahori T; Jin S; Kawanokuchi J; Noda M; Iwakura Y; Mizuno T; Suzumura A
J Immunol; 2011 Apr; 186(7):4415-21. PubMed ID: 21346235
[TBL] [Abstract][Full Text] [Related]
20. Evidence for local and systemic activation of immune cells by peritumoral injections of interleukin 2 in patients with advanced squamous cell carcinoma of the head and neck.
Whiteside TL; Letessier E; Hirabayashi H; Vitolo D; Bryant J; Barnes L; Snyderman C; Johnson JT; Myers E; Herberman RB
Cancer Res; 1993 Dec; 53(23):5654-62. PubMed ID: 8242620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
